Dr. Roman E. Perri, MD

Dr. Perri practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Perri's NPI, 1457339707, was assigned on January 6, 2006. Dr. Perri graduated from University of Wisconsin School of Medicine in 1999. Dr. Perri holds Tennessee license 41122.

Dr. Perri's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Perri's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Perri is also affiliated with Deaconess Midtown Hospital. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Perri to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perri practices, 5 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Perri's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dmand AI has Dr. Perri's licenses on file in 2 states: Tennessee and Minnesota.

CMS data shows 415 Medicare services from Dr. Perri across 13 procedure codes in 2024, for 324 Medicare patients. Medicare paid $39,680 for them.

CMS counts 324 Medicare patients who saw Dr. Perri in 2024. The largest group is 65 to 74, with 181 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Perri's median patient age at 64, with 50% women.

In 2024, Dr. Perri wrote 623 Medicare Part D claims for 188 patients. 79% of them were for generic drugs. CMS names the drug for 475 of them, across 16 drugs with 11 or more claims each, at $243,079 in total drug cost. In 2023, CMS named 603 claims across 20 drugs.

Dr. Perri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Perri as offering telehealth. CMS counts 106 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Perri, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Perri, published from 2018 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Antiviral Agents, Heart Transplantation and Hepatitis C. Dr. Perri has published most often in Transplant Direct. Dr. Perri's most frequent co-authors are Kelly Hulett Schlendorf, MD, MHS, Joseph A. Awad, MD and Douglas Marshall Brinkley, MD.

Dmand AI links Dr. Perri to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Cholangitis, Sclerosing, Liver Diseases and Cholangitis.

CMS Open Payments shows 2 general payments to Dr. Perri from 2 drug and device companies from 2024 to 2025. Honoraria make up the largest share, 94% of the total. Octapharma USA, Inc. paid the most, $2,000.

Dr. Perri graduated from University of Wisconsin School of Medicine in 1999.